Chimera Investment - 9% NT REDEEM 15/05/2029 USD 25 Receivables

Chimera Investment - 9% NT REDEEM 15/05/2029 USD 25 posts a receivables of $110M as of June 2026. That compares with $75M in the prior-year period — up 50.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Chimera Investment - 9% NT REDEEM 15/05/2029 USD 25's receivables was $75M. The latest reading is $110M — a 50.0% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Chimera Investment - 9% NT REDEEM 15/05/2029 USD 25's financial statement story. At $110M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CIMN's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Chimera Investment - 9% NT REDEEM 15/05/2029 USD 25's other metric pages and overview cover the third.

Judging Chimera Investment - 9% NT REDEEM 15/05/2029 USD 25 against Finance peers is usually better than using a market-wide rule of thumb. Business models inside Finance are more comparable, which makes gaps in receivables easier to interpret. Start with $110M here, then scan peer and history charts to see if the gap is persistent.